Oliver M. Whittington
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Oliver M. Whittington has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Alan Farney
Section of Abdominal Organ Transplantation, Department of Surgery Atrium Health Wake Forest Baptist Hospital, Wake Forest University School of Medicine Winston‐Salem North Carolina USA
1 shared publicationBeth M. Roberts
Memphis Zoo, Conservation and Research Department, 2000 Prentiss Place, Memphis, TN, 38112, USA
1 shared publicationChris Webb
Section of Abdominal Organ Transplantation, Department of Surgery Atrium Health Wake Forest Baptist Hospital, Wake Forest University School of Medicine Winston‐Salem North Carolina USA
1 shared publication- Colleen Jay
Division of Transplant Surgery, Department of Surgery Atrium Health Carolinas Medical Center, Wake Forest University School of Medicine Charlotte North Carolina USA
1 shared publication Emily McCracken
Section of Abdominal Organ Transplantation, Department of Surgery Atrium Health Wake Forest Baptist Hospital, Wake Forest University School of Medicine Winston‐Salem North Carolina USA
1 shared publicationGiuseppe Orlando
Section of Abdominal Organ Transplantation, Department of Surgery Atrium Health Wake Forest Baptist Hospital, Wake Forest University School of Medicine Winston‐Salem North Carolina USA
1 shared publication
Latest Publications
- 29 July 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (8) , e70618
Keeping Our Promise: Expedited Allocation for Prior Living Kidney Donors and Trends in Waiting Times According to Race
Introduction: Risks of kidney failure among prior living kidney donors (LKDs) are low, but an updated analysis of the impact of donor allocation priority on waiting times accounting for allocation changes and race has not been documented. Methods: Using national UNOS data, we compared transplant rates, waiting time, and time on dialysis for prior LKDs with matched controls. Waiting time was calculated based on initial registration and end waitlist date. Results: Transplant rate was 86.2 per 100 person years for LKD and 20.4 for matched controls ( p < 0.001) corresponding to 83% of prior LKDs transplanted compared to 50% of matched controls ( p < 0.001). Median waiting time was 93 (27–371) days in the LKD group versus 692 (233–1351) days in the matched control group ( p < 0.001). LKD waiting time pre‐ and post‐implementation of the “new” Kidney Allocation System (KAS) was 133 (42–516) versus 67 (19–226) days, ( p < 0.001). For LKDs, 56% were on dialysis prior to listing and 61% prior to transplant compared to 66% and 82% in controls, (both p < 0.001). Time on dialysis among LKDs post‐KAS was comparable (pre‐KAS: 547 (259–1352) versus post‐KAS: 461 (231–942) days, p = 0.06). Waiting times were comparable according to race and ethnicity, but Black LKDs were more often on dialysis at the time of listing (Black 61% vs. white: 52%, p = 0.02), and time on dialysis was 36% (+155 days) longer in Black versus white LKDs ( p = 0.0002). Conclusions: LKD allocation priority results in a higher transplant rate and significant reduction in waiting time compared to matched controls, which improved post‐KAS 2014. Concerning, more than half of LKDs are on dialysis prior to listing and transplant with no substantial improvements in the post‐KAS era. Black LKDs experience lower transplant rates, 36% longer dialysis time compared to white LKDs, and are more likely to be on dialysis prior to listing and transplant. Improved monitoring of LKDs and earlier transplant referrals are needed.
- 29 July 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (8) , e70618
Keeping Our Promise: Expedited Allocation for Prior Living Kidney Donors and Trends in Waiting Times According to Race
Introduction: Risks of kidney failure among prior living kidney donors (LKDs) are low, but an updated analysis of the impact of donor allocation priority on waiting times accounting for allocation changes and race has not been documented. Methods: Using national UNOS data, we compared transplant rates, waiting time, and time on dialysis for prior LKDs with matched controls. Waiting time was calculated based on initial registration and end waitlist date. Results: Transplant rate was 86.2 per 100 person years for LKD and 20.4 for matched controls ( p < 0.001) corresponding to 83% of prior LKDs transplanted compared to 50% of matched controls ( p < 0.001). Median waiting time was 93 (27–371) days in the LKD group versus 692 (233–1351) days in the matched control group ( p < 0.001). LKD waiting time pre‐ and post‐implementation of the “new” Kidney Allocation System (KAS) was 133 (42–516) versus 67 (19–226) days, ( p < 0.001). For LKDs, 56% were on dialysis prior to listing and 61% prior to transplant compared to 66% and 82% in controls, (both p < 0.001). Time on dialysis among LKDs post‐KAS was comparable (pre‐KAS: 547 (259–1352) versus post‐KAS: 461 (231–942) days, p = 0.06). Waiting times were comparable according to race and ethnicity, but Black LKDs were more often on dialysis at the time of listing (Black 61% vs. white: 52%, p = 0.02), and time on dialysis was 36% (+155 days) longer in Black versus white LKDs ( p = 0.0002). Conclusions: LKD allocation priority results in a higher transplant rate and significant reduction in waiting time compared to matched controls, which improved post‐KAS 2014. Concerning, more than half of LKDs are on dialysis prior to listing and transplant with no substantial improvements in the post‐KAS era. Black LKDs experience lower transplant rates, 36% longer dialysis time compared to white LKDs, and are more likely to be on dialysis prior to listing and transplant. Improved monitoring of LKDs and earlier transplant referrals are needed.